FAP and pancreatic neoplasm: PTRT with 177Lu-FAP-2286 appears to ameliorate symptoms in rapidly proliferating adenocarcinomas as noted by significant pain reduction in patient 4, with liver metastases; patient 6, with diffuse bone metastases; and patient 5, with newly diagnosed pancreatic cancer.